Cargando…

Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening

BACKGROUND: Breast cancer is a common disease in Tunisia and is associated with high mortality rates. The “Instance Nationale de l’Evaluation et de l’Accréditation en Santé” (INEAS) and the Tunisian Society of Oncology decided to develop practice guidelines on the subject. While the development of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahale, Lara A., Ouertatani, Hella, Brahem, Asma Ben, Grati, Hela, Hamouda, Mohammed Ben, Saz-Parkinson, Zuleika, Akl, Elie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117583/
https://www.ncbi.nlm.nih.gov/pubmed/33985535
http://dx.doi.org/10.1186/s12961-021-00731-z
_version_ 1783691610666565632
author Kahale, Lara A.
Ouertatani, Hella
Brahem, Asma Ben
Grati, Hela
Hamouda, Mohammed Ben
Saz-Parkinson, Zuleika
Akl, Elie A.
author_facet Kahale, Lara A.
Ouertatani, Hella
Brahem, Asma Ben
Grati, Hela
Hamouda, Mohammed Ben
Saz-Parkinson, Zuleika
Akl, Elie A.
author_sort Kahale, Lara A.
collection PubMed
description BACKGROUND: Breast cancer is a common disease in Tunisia and is associated with high mortality rates. The “Instance Nationale de l’Evaluation et de l’Accréditation en Santé” (INEAS) and the Tunisian Society of Oncology decided to develop practice guidelines on the subject. While the development of de novo guidelines on breast cancer screening is a demanding process, guideline adaptation appears more appropriate and context sensitive. The objective of this paper is to describe the adaptation process of the European Guidelines on Breast Cancer Screening and Diagnosis to the Tunisian setting in terms of the methodological process, contextual differences between the source and adoloped guideline, and changes in the recommendations. METHODS: We used the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE)-ADOLOPMENT methodology to prioritize the topic, select the source guideline, and prioritize the questions and the outcomes. Once the source guideline was selected—the European Breast Cancer Guidelines—the European Commission´s Joint Research Centre shared with the project team in Tunisia all relevant documents and files. In parallel, the project team searched for local studies on the disease prevalence, associated outcomes’ baseline risks, patients’ values and preferences, cost, cost-effectiveness, acceptability, and feasibility. Then, the adoloping panel reviewed the GRADE evidence tables and the Evidence to Decision tables and discussed whether their own judgments were consistent with those from the source guideline or not. They based their judgments on the evidence on health effects, the contextual evidence, and their own experiences. RESULTS: The most relevant contextual differences between the source and adoloped guidelines were related to the perspective, scope, prioritized questions, rating of outcome importance, baseline risks, and indirectness of the evidence. The ADOLOPMENT process resulted in keeping 5 out of 6 recommendations unmodified. One recommendation addressing “screening versus no screening with ultrasound in women with high breast density on mammography screening” was modified from ‘conditional against’ to ‘conditional for either’ due to more favorable ratings by the adoloping panel in terms of equity and feasibility. CONCLUSION: This process illustrates both the feasibility of GRADE-ADOLOPMENT approach and the importance of consideration of contextual evidence. It also highlights the value of collaboration with the organization that developed the source guideline.
format Online
Article
Text
id pubmed-8117583
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81175832021-05-13 Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening Kahale, Lara A. Ouertatani, Hella Brahem, Asma Ben Grati, Hela Hamouda, Mohammed Ben Saz-Parkinson, Zuleika Akl, Elie A. Health Res Policy Syst Research BACKGROUND: Breast cancer is a common disease in Tunisia and is associated with high mortality rates. The “Instance Nationale de l’Evaluation et de l’Accréditation en Santé” (INEAS) and the Tunisian Society of Oncology decided to develop practice guidelines on the subject. While the development of de novo guidelines on breast cancer screening is a demanding process, guideline adaptation appears more appropriate and context sensitive. The objective of this paper is to describe the adaptation process of the European Guidelines on Breast Cancer Screening and Diagnosis to the Tunisian setting in terms of the methodological process, contextual differences between the source and adoloped guideline, and changes in the recommendations. METHODS: We used the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE)-ADOLOPMENT methodology to prioritize the topic, select the source guideline, and prioritize the questions and the outcomes. Once the source guideline was selected—the European Breast Cancer Guidelines—the European Commission´s Joint Research Centre shared with the project team in Tunisia all relevant documents and files. In parallel, the project team searched for local studies on the disease prevalence, associated outcomes’ baseline risks, patients’ values and preferences, cost, cost-effectiveness, acceptability, and feasibility. Then, the adoloping panel reviewed the GRADE evidence tables and the Evidence to Decision tables and discussed whether their own judgments were consistent with those from the source guideline or not. They based their judgments on the evidence on health effects, the contextual evidence, and their own experiences. RESULTS: The most relevant contextual differences between the source and adoloped guidelines were related to the perspective, scope, prioritized questions, rating of outcome importance, baseline risks, and indirectness of the evidence. The ADOLOPMENT process resulted in keeping 5 out of 6 recommendations unmodified. One recommendation addressing “screening versus no screening with ultrasound in women with high breast density on mammography screening” was modified from ‘conditional against’ to ‘conditional for either’ due to more favorable ratings by the adoloping panel in terms of equity and feasibility. CONCLUSION: This process illustrates both the feasibility of GRADE-ADOLOPMENT approach and the importance of consideration of contextual evidence. It also highlights the value of collaboration with the organization that developed the source guideline. BioMed Central 2021-05-13 /pmc/articles/PMC8117583/ /pubmed/33985535 http://dx.doi.org/10.1186/s12961-021-00731-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kahale, Lara A.
Ouertatani, Hella
Brahem, Asma Ben
Grati, Hela
Hamouda, Mohammed Ben
Saz-Parkinson, Zuleika
Akl, Elie A.
Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening
title Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening
title_full Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening
title_fullStr Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening
title_full_unstemmed Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening
title_short Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening
title_sort contextual differences considered in the tunisian adolopment of the european guidelines on breast cancer screening
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117583/
https://www.ncbi.nlm.nih.gov/pubmed/33985535
http://dx.doi.org/10.1186/s12961-021-00731-z
work_keys_str_mv AT kahalelaraa contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening
AT ouertatanihella contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening
AT brahemasmaben contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening
AT gratihela contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening
AT hamoudamohammedben contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening
AT sazparkinsonzuleika contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening
AT akleliea contextualdifferencesconsideredinthetunisianadolopmentoftheeuropeanguidelinesonbreastcancerscreening